Filing Flows › Lifevantage (LFVN) › R&D spending
Lifevantage (LFVN) R&D spending by quarter
Lifevantage's R&D spending was $200K in Q2 2026 (second quarter 2026), 0% from Q1 2026. Over the last 7 quarters it ranged from $200K (Q2 2026) to $400K (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $200K | 0% | -50% |
| Q1 2026 | $200K | 0% | -50% |
| Q4 2025 | $200K | -33% | 0% |
| Q3 2025 | $300K | -25% | — |
| Q2 2025 | $400K | 0% | — |
| Q1 2025 | $400K | +100% | — |
| Q4 2024 | $200K | — | — |
Q2 2026 at a glance
Lifevantage, Q2 2026: revenue $42.4M (-23% year over year), operating margin 3.9%, net earnings $1.3M, operating cash flow $4.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lifevantage's R&D spending?
Lifevantage's R&D spending was $200K in Q2 2026 (second quarter 2026), 0% from Q1 2026.
How has Lifevantage's R&D spending changed?
Over the last 7 quarters it ranged from $200K (Q2 2026) to $400K (Q2 2025).